Serological Identification of URGCP as a Potential Biomarker for Glioma.

CONCLUSION: We identified a potential new biomarker of GBM, URGCP. The findings indicate that URGCP is immunogenic in human GBM and suggest its potential use as diagnostic and immunotherapeutic for GBM patients.
PMID: 24308561 [PubMed - as supplied by publisher]

Source: CNS Neuroscience and Therapeutics - December 6, 2013 Category: Neuroscience Authors: Chen LC, Zhang HY, Qin ZY, Wang Y, Mao Y, Yao Y, Zhou LF Tags: CNS Neurosci Ther Source Type: research